doi:10.1177/0333102418821661 Post #2027
Glucagon-like peptide-1 (GLP-1) naturally suppresses appetite and slows stomach emptyingtwo effects that disappear once the medication stops
At the highest dose (15 mg), nausea was reported in 31% of patients, diarrhoea in 23%, vomiting in 12.1%, constipation in 11.7%, and indigestion in 11.3%
A GLP-1 receptor agonist is a medication that mimics the natural GLP-1 hormone
This: Improves adherence (fewer missed doses) Provides more consistent drug levels Is more convenient for patients Better tolerability at higher efficacy Both medications can cause stomach-related side effects like nausea, diarrhea, and constipation
Addressing obesity, a known risk factor and disease modifier in HS, may lead to better disease control